Leonteq Securities AG’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$397K Buy
2,038
+481
+31% +$99.7K 0.01% 449
2026
Q1
$350K Buy
1,557
+28
+2% +$6.98K 0.01% 483
2025
Q4
$368K Buy
1,529
+912
+148% +$233K 0.01% 523
2025
Q3
$169K Buy
617
+238
+63% +$65K 0.01% 628
2025
Q2
$97.8K Sell
379
-792
-68% -$189K ﹤0.01% 720
2025
Q1
$262K Buy
1,171
+583
+99% +$136K 0.01% 489
2024
Q4
$134K Buy
588
+12
+2% +$2.89K 0.01% 627
2024
Q3
$141K Buy
576
+149
+35% +$33.3K 0.01% 556
2024
Q2
$81.7K Sell
427
-55
-11% -$11.2K 0.01% 660
2024
Q1
$95.5K Sell
482
-1,281
-73% -$235K 0.01% 644
2023
Q4
$303K Sell
1,763
-206
-10% -$31.7K 0.02% 415
2023
Q3
$291K Buy
1,969
+1,591
+421% +$288K 0.02% 450
2023
Q2
$82.6K Buy
378
+147
+64% +$32.8K ﹤0.01% 725
2023
Q1
$50.6K Sell
231
-355
-61% -$77K ﹤0.01% 797
2022
Q4
$122K Buy
586
+126
+27% +$27.7K ﹤0.01% 639
2022
Q3
$100K Sell
460
-618
-57% -$141K ﹤0.01% 644
2022
Q2
$226K Sell
1,078
-50
-4% -$10.6K 0.01% 527
2022
Q1
$274K Buy
1,128
+144
+15% +$34.8K 0.01% 523
2021
Q4
$256K Buy
984
+284
+41% +$73.7K 0.01% 566
2021
Q3
$184K Sell
700
-6
-0.8% -$1.64K 0.01% 605
2021
Q2
$174K Sell
706
-100
-12% -$21K 0.01% 602
2021
Q1
$156K Buy
806
+502
+165% +$101K 0.01% 591
2020
Q4
$64.6K Buy
+304
New +$60.6K ﹤0.01% 745

Other funds holding RMD

Leonteq Securities AG's RMD Position: Q2 2026 in Review

Leonteq Securities AG increased its ResMed (RMD) stake by 31% in Q2 2026, buying an estimated $99.7K and bringing the position to 2,038 shares worth $397K. The position accounts for 0.01% of the portfolio, ranked #449.

Leonteq Securities AG first reported a position in RMD in Q4 2020 and has held it in 23 quarters since. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Leonteq Securities AG held 2,038 shares of ResMed worth $397K as of Q2 2026.
  • Leonteq Securities AG bought 481 ResMed shares in Q2 2026, an estimated $99.7K.
  • ResMed made up 0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #449 holding.
  • Leonteq Securities AG first reported a position in ResMed in Q4 2020 and has held it in 23 quarters since.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.